Structure and mechanism of interleukin-1 beta converting enzyme. 1994

K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139.

Interleukin-1 beta converting enzyme (ICE) processes an inactive precursor to the proinflammatory cytokine, interleukin-1 beta, and may regulate programmed cell death in neuronal cells. The high-resolution structure of human ICE in complex with an inhibitor has been determined by X-ray diffraction. The structure confirms the relationship between human ICE and cell-death proteins in other organisms. The active site spans both the 10 and 20K subunits, which associate to form a tetramer, suggesting a mechanism for ICE autoactivation.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell

Related Publications

K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
January 1997, Vitamins and hormones,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
January 1994, Methods in enzymology,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
September 1998, Annals of the New York Academy of Sciences,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
April 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
April 1992, Science (New York, N.Y.),
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
May 1995, The Journal of experimental medicine,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
August 1992, Archives of biochemistry and biophysics,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
March 1996, Cytokines and molecular therapy,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
January 1994, International journal of peptide and protein research,
K P Wilson, and J A Black, and J A Thomson, and E E Kim, and J P Griffith, and M A Navia, and M A Murcko, and S P Chambers, and R A Aldape, and S A Raybuck
January 1997, Journal of cellular biochemistry,
Copied contents to your clipboard!